BetterLife is a life sciences company creating and clinically validating an evolving intellectual property portfolio of novel molecules and drug delivery mechanisms for clinical trials and commercialization.
Patient-friendly answer to mental health’s unmet needs: Developing two neurological compounds that are desperately needed
Potential treatment of COVID-19 variants leading to lower hospitalization and death rate: Novel anti-viral drugs for treatment and potential prevention of pandemics.
Management with extensive experience in all aspects of drug development and public company and capital markets management.
Several near- and medium-term growth drivers: Growing mental health & COVID-19 markets.
STOCK QUOTE: BETR
STOCK QUOTE: BETRF
Andre Uddin, Analyst at Research Capital Corporation